EMEA-000352-PIP01-08-M01
Key facts
| Active substance |
Motavizumab
|
| Therapeutic area |
Neonatology-Paediatric Intensive Care
|
| Decision number |
P/199/2010
|
| PIP number |
EMEA-000352-PIP01-08-M01
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Serious lower respiratory tract disease caused by respiratory syncytial virus (RSV)
|
| Route(s) of administration |
Intramuscular use
|
| Contact for public enquiries |
AbbVie Ltd
|
| Decision type |
PM: decision on the application for modification of an agreed PIP
|